Multiparity increases trophoblast invasion and vascular endothelial growth factor expression at the maternal-fetal interface in mice

Journal of Reproductive Immunology

Volumn 85, Issue 2, 2010, Pages 161-167

  Litwin, Silvana ^a   Cortina, María E ^a   Barrientos, Gabriela L ^a   Prados, María B ^a   Roux, María E ^b   Miranda, Silvia E ^a  

^a Instituto de Investigaciones Cardiologicos Dr Alberto C Taquini   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Mouse; Multiparity; Placenta; Trophoblast invasion; VEGF

Indexed keywords

CYTOKERATIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MALE; MOUSE; MULTIPARA; NONHUMAN; PLACENTA; PREGNANCY OUTCOME; PRIMIPARA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST;

ABORTION, SPONTANEOUS; ANIMALS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, INBRED DBA; PARITY; PREGNANCY; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 77953612761     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.03.004     Document Type: Article

References (33)

1. Adamson S.L., Lu Y., Whiteley K.J., Holmyard D., Hemberger M., Pfarrer C., Cross J.C. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev. Biol. 2002, 250:358-373.
2. Anteby E.Y., Greenfield C., Natanson-Yaron S., Goldman-Wohl D., Hamani Y., Khudyak V., Ariel I., Yagel S. Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol. Hum. Reprod. 2004, 10(4):229-235.
3. Beer A., Scott J., Billingham R. Histocompatibility and maternal immunological status as determinants of feto-placental size and litter weight in rodents. J. Exp. Med. 1975, 9:704-713.
4. Breier G., Clauss M., Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev. Dyn. 1995, 204:228-239.
5. Chakraborty I., Das S.K., Dey S.K. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation. J. Endocrinol. 1995, 147:339-352.
6. Chavez D.J., McIntyre J.A., Colliver J.A., Page Faulk W. Allogeneic matings and immunization have different effects on nulliparous and multiparous mice. J. Immunol. 1987, 139:85-88.
7. Coulam C.B., Jeyendran R.S. Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. Am. J. Reprod. Immunol. 2008, 59:301-305.
8. Derrell Clark J.D., Baldwin R.L., Bayne K.A., Brown M.J., Gebhart G.F., Gonder J.C., Gwathmey J.K., Keeling M.E., Kohn D.F., Robb J.W., Smith O.A., Steggerda A.D., Vandenbergh J.G., White W.J., Williams-Blangero S., VandeBerg J.L. Guide for the Care and Use of Laboratory Animals 1996, Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council, National Academy Press, Washington, DC.
9. Dumont D.J., Fong G.H., Purin M.C., Gradwohl G., Alitalo K., Breitman M.L. Vascularization of the mouse embryo: a study of flk-1, tek, tie and vascular endothelial growth factor expression during development. Dev. Dyn. 1995, 203:80-92.
10. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
11. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997, 18:4-25.
12. Fong G.H., Rossant J., Gertenstein M., Breitman M. Role of Flt-1 receptor tyrosine kinase in regulation of assembly of vascular endothelium. Nature 1995, 376:66-67.
13. He Y., Smith S., Day K., Clark D., Licence D., Charnock-Jones S. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (Flt-1) pre-RNA is important for the regulation of VEGF activity. Mol. Endocrinol. 1999, 13:537-544.
14. Hidaka T., Fujimura M., Nakashima A., Higuma S., Yamagishi N., Sakai M., Saito S. Macrophage colony stimulating factor (M-CSF) prevents infections death induced by chemotherapy in mice, while granulocyte-CSF does not. Jpn. J. Cancer Res. 2002, 93:426-435.
15. Hirashima M., Lu Y., Rossant J. Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15637-15642.
16. Kendall R.L., Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:10705-10709.
17. Lagadari M., Blois S., Margni R., Miranda S. Analysis of macrophage presence in murine placenta. Influence of age and parity status. Am. J. Reprod. Immunol. 2004, 51:49-55.
18. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., Schisterman E.F., Thadhani R., Sachs B.P., Epstein F.H., Sibai B.M., Sukhatme V.P., Karumanchi S.A. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004, 350:672-683.
19. Litwin S., Lagadari M., Barrientos G., Roux M.E., Margni R., Miranda S. Comparative immunohistochemical study of M-CSF and G-CSF in feto-maternal interface in a multiparity mouse model. Am. J. Reprod. Immunol. 2005, 54:1-10.
20. Mandriota S., Montesano R., Orci L., Seghezzi G., Vassalli J.D., Ferrara N., Mignatti P., Pepper M.S. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem. 1995, 270:9709-9716.
21. Maynard S.M., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., Libermann T., Morgan J., Sellke F., Stillman I., Epstein F., Sukhatme V., Ananth Karumanchi S. Excess placental soluble fms-like tyrosine kinase I (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003, 111:649-658.
22. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999, 13:9-22.
23. Park J.E., Keller G.A., Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into subepithelial extracellular matrix and bioactivity of ECM-bound VEGF. Mol. Biol. Cell. 1993, 4:1317-1326.
24. Pepper M.S., Ferrara N., Orci L., Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 1991, 181:902-908.
25. Prefumo F., Ganapathy R., Thilaganathan B., Sebire N.J. Influence of parity on first trimester endovascular trophoblast invasion. Fertil. Steril. 2006, 85:1032-1036.
26. Redline R.W., Lu C.Y. Localization of fetal major histocompatibility complex antigens and maternal leukocytes in murine placenta. Implications for maternal-fetal immunological relationship. Lab. Invest. 1989, 61:27-36.
27. Robillard P., Dekker G., Hulsey T. Revisiting the epidemiological standard of pre-eclampsia: primigravidity of primipaternity?. Eur. J. Obstet. Gynecol. Reprod. Biol. 1999, 84:37-41.
28. Saint Marie G. A paraffin embedding technique for studies employing immunofluorescence. J. Histochem. Cytochem. 1962, 10:250-256.
29. Shima D.T., Kuroki M., Deutsch U., Ng Y.S., Adamis A.P., D'Amore P.A. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 1996, 271:3877-3883.
30. Trupin L., Simon L., Eskenazi B. Change in paternity: a risk factor for pre-eclampsia in multiparas. Epidemiology 1996, 7:240-244.
31. Unemori E.N., Ferrara N., Bauer E.A., Amento E.P. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell Physiol. 1992, 153:557-562.
32. Vuorela P., Carpén O., Tulppala M., Halmesmäki E. VEGF, its receptors and the Tie receptors in recurrent miscarriage. Mol. Hum. Reprod. 2000, 6:276-282.
33. Wolf M., Shan A., Lam C., Martínez A., Smirnakis K.V., Epstein F.H., Taylor R.N., Ecker J.L., Karumanchi S.A., Thadhani R. Circulating levels of the antiangiogenic marker sFLT-1 are increased in the first versus second pregnancies. Am. J. Obstet. Gynecol. 2005, 193:16-22.